Magalie Penaud‐Budloo

1.5k citations

24 papers · 1.0k indexed · h-index 15

Genetics top 2%
- Virus-based gene therapy research 23
Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 13
- CRISPR and Genetic Engineering 10
- RNA Interference and Gene Delivery 9
Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology 3
Virology
Oncology
- CAR-T cell therapy research 2
Epidemiology
- Herpesvirus Infections and Treatments 3
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 1

Co-authors: Eduard Ayuso Philippe Moullier Richard O. Snyder Caroline Le Guiner Achille François Nathalie Clément Manfred Schmidt Véronique Blouin
Cited by: Genetics Molecular Biology Infectious Diseases
Journals: Molecular Therapy — Methods & Clinical Development (6 papers)Molecular Therapy (3 papers)Journal of Virology (3 papers)
Partner nations: France United States Germany

In The Last Decade

Magalie Penaud‐Budloo

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Magalie Penaud‐Budloo

Since Specialization

Citations

This map shows the geographic impact of Magalie Penaud‐Budloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magalie Penaud‐Budloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magalie Penaud‐Budloo more than expected).

Fields of papers citing papers by Magalie Penaud‐Budloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magalie Penaud‐Budloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magalie Penaud‐Budloo. The network helps show where Magalie Penaud‐Budloo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Magalie Penaud‐Budloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Magalie Penaud‐Budloo Line = papers co-authored together Magalie Penaud‐Budloo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of residual microRNAs in AAV vector batches produced in HEK293 mammalian cells and Sf9 insect cells Molecular Therapy — Methods & Clinical Development ·Magalie Penaud‐Budloo,P S Wong,Kouicni Morita,Simon Pacouret,杨春杰,幸夫伏田,Dwi Mayaheti Nasution,Laurence Jeanson-Leh,عبدالله محمد حافظ,Véronique Blouin,Eduard Ayuso,Oumeya Adjali	2024	3
2	Analytical ultracentrifugation sedimentation velocity for the characterization of recombinant adeno-associated virus vectors sub-populations European Biophysics Journal ·Sylvie Saleün,Caroline Mas,Aline Le Roy,Magalie Penaud‐Budloo,Oumeya Adjali,Véronique Blouin,Christine Ebel	2023	8
3	Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity Human Gene Therapy ·Jue Shan,P S Wong,Sylvie Saleün,Suk Namkung,عبدالله محمد حافظ,Kristina Weber,Eric Devine,Véronique Blouin,Oumeya Adjali,Eduard Ayuso,Guangping Gao,Magalie Penaud‐Budloo,Phillip W.L. Tai	2022	50
4	The SSV‐Seq 2.0 PCR‐Free Method Improves the Sequencing of Adeno‐Associated Viral Vector Genomes Containing GC‐Rich Regions and Homopolymers Biotechnology Journal ·P S Wong,Sylvie Saleün,周林裕,幸夫伏田,Oumeya Adjali,Véronique Blouin,Magalie Penaud‐Budloo,Eduard Ayuso	2020	9
5	Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries Molecular Therapy — Methods & Clinical Development ·Jian-Jia Liu,Simon Pacouret,Eric Zinn,Elizabeth A.R. Telford,Fotini Nicolaou,杨春杰,Eva Andrés‐Mateos,Ru Xiao,Magalie Penaud‐Budloo,Mohammed Bouzelha,Guyo Sora,Oumeya Adjali,Eduard Ayuso,Luk H. Vandenberghe	2019	24
6	Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of Adeno-Associated Virus Serotypes Journal of Pharmaceutical Sciences ·V. D. Babiuk,Magalie Penaud‐Budloo,Mohammed Bouzelha,Axel Rossi,Tim Menzen,Martin Biel,Hildegard Büning,Eduard Ayuso,Gerhard Winter,Stylianos Michalakis	2019	18
7	Stability of the adeno-associated virus 8 reference standard material Gene Therapy ·Magalie Penaud‐Budloo,杨春杰,Andrea L. Maser,Mohammed Bouzelha,Sylvie Saleün,Sara C. Bronin,Susan D’Costa,Steven J. Gagliardi,Oumeya Adjali,Véronique Blouin,Martin Lock,Richard O. Snyder,Eduard Ayuso	2019	10
8	Single-Stranded DNA Virus Sequencing (SSV-Seq) for Characterization of Residual DNA and AAV Vector Genomes Methods in molecular biology ·P S Wong,Adrien Léger,Magalie Penaud‐Budloo,Eduard Ayuso	2019	10
9	Pharmacology of Recombinant Adeno-associated Virus Production Molecular Therapy — Methods & Clinical Development ·Magalie Penaud‐Budloo,Achille François,Nathalie Clément,Eduard Ayuso	2018	133
10	Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls Molecular Therapy — Methods & Clinical Development ·Achille François,Mohammed Bouzelha,P S Wong,杨春杰,Magalie Penaud‐Budloo,Oumeya Adjali,Philippe Moullier,Véronique Blouin,Eduard Ayuso	2018	40
11	AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations Molecular Therapy ·Simon Pacouret,Mohammed Bouzelha,Rajani Shelke,Eva Andrés‐Mateos,Ru Xiao,Anna C. Maurer,Mathieu Mével,Heikki Turunen,Chengbing Liu,Magalie Penaud‐Budloo,杨春杰,Véronique Blouin,Philippe Moullier,Eduard Ayuso,Luk H. Vandenberghe	2017	53
12	Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells Human Gene Therapy Methods ·Magalie Penaud‐Budloo,P S Wong,幸夫伏田,Sylvie Saleün,Alain Roulet,Céline Lopez‐Roques,G. Montresor,Benjamin Cogné,Adrien Léger,Véronique Blouin,Pierre Lindenbaum,Philippe Moullier,Eduard Ayuso	2017	37
13	Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells Journal of Virology ·Stefanie Große,Magalie Penaud‐Budloo,Junxian WU,Kathleen Börner,Julia Fakhiri,Vibor Laketa,L.F. Truett,Ellen Wiedtke,Manuel Gunkel,Ma Xinyi,Eduard Ayuso,Dirk Grimm	2017	39
14	Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA Molecular Therapy — Methods & Clinical Development ·Dwi Mayaheti Nasution,G. Montresor,Christophe Georger,Béatrice Marolleau,Laurence Jeanson-Leh,Mireille Ledevin,Pierre Lindenbaum,P S Wong,Benjamin Cogné,Laurence Dubreil,Thibaut Larcher,Bernard Gjata,Laetitia van Wittenberghe,Caroline Le Guiner,Magalie Penaud‐Budloo,Richard O. Snyder,Philippe Moullier,Adrien Léger	2015	14
15	Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver Molecular Therapy ·Ali Nowrouzi,Magalie Penaud‐Budloo,Christine Kaeppel,Uwe Appelt,Caroline Le Guiner,Philippe Moullier,Christof von Kalle,Richard O. Snyder,Manfred Schmidt	2012	82
16	Evaluation of the Fate of rAAV Genomes Following In Vivo Administration Methods in molecular biology ·K. Reed Clark,Magalie Penaud‐Budloo	2011	4
17	Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle PLoS ONE ·Adrien Léger,Caroline Le Guiner,Michael L. Nickerson,Kate M. Im,Nicolas Ferry,Philippe Moullier,Richard O. Snyder,Magalie Penaud‐Budloo	2011	14
18	Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping Gene Therapy ·Мырзатаева,Caroline Le Guiner,Gwladys Gernoux,Magalie Penaud‐Budloo,Philippe Moullier,Richard O. Snyder	2011	43
19	Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle Molecular Therapy ·Alice Toromanoff,Yan Chérel,Mickaël Guilbaud,Magalie Penaud‐Budloo,Richard O. Snyder,Mark E. Haskins,Jack‐Yves Deschamps,Lydie Guigand,Guillaume Podevin,Valder R. Arruda,Katherine A. High,Hansell H. Stedman,Fabienne Rolling,Ignacio Anegón,Philippe Moullier,Caroline Le Guiner	2008	74
20	Early Detection of a Two-Long-Terminal-Repeat Junction Molecule in the Cytoplasm of Recombinant Murine Leukemia Virus-Infected Cells Journal of Virology ·Fatima Serhan,Magalie Penaud‐Budloo,Caroline Petit,Thierry Lesté-Lasserre,HEt Derson G N,David Klatzmann,Ghislaine Duisit,P. Sonigo,Philippe Moullier	2004	14

About Magalie Penaud‐Budloo

Magalie Penaud‐Budloo is a scholar working on Genetics, Molecular Biology and Infectious Diseases, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), Viral Infectious Diseases and Gene Expression in Insects (13 papers), CRISPR and Genetic Engineering (10 papers), RNA Interference and Gene Delivery (9 papers), Viral gastroenteritis research and epidemiology (3 papers), Herpesvirus Infections and Treatments (3 papers), CAR-T cell therapy research (2 papers) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Genetics (804 citations), Molecular Biology (829 citations) and Infectious Diseases (149 citations). Magalie Penaud‐Budloo has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Eduard Ayuso, Philippe Moullier, Richard O. Snyder, Caroline Le Guiner, Achille François, Nathalie Clément, Manfred Schmidt, Véronique Blouin, Ali Nowrouzi and Christof von Kalle. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, Molecular Therapy, Journal of Virology, Gene Therapy and Biotechnology Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact